Skip to main content
. 2017 May 19;12:13. doi: 10.1186/s13020-017-0134-0

Fig. 9.

Fig. 9

JTD reduces MA/UCREA in DN patients after 12 weeks administration. *P < 0.05; **P < 0.01; and ***P < 0.001 compared with the patients before treatment